MedTrace Logo

Smoking Cessation for Patients With Acute Coronary Syndrome (ACS)

NCT00987597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2016-12-26

No results posted yet for this study

Summary

The aim of the present study is to assess if a personal care program of smokers hospitalised for acute coronary syndrome can change the smoking habits as compared with similar patients in conventional care program at 6 months. The program includes a cognitive-behavioural approach associated with a nicotine replacement treatment presented as an obligatory non optional treatment. Patients are men and women of less than 70 years old hospitalised for acute coronary syndrome. Major exclusion criteria is the presence of another dependence. The program includes a cognitive-behavioural approach based on the specific technique of "exposure" and the prescription of nicotine patch considered as other usual cardiologic treatments for at least 6 months. The end point is the smoking habits at 6 months classified as: no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level \> 10 ppm). 72 patients in each group will be included in 2 majors sites.

Conditions

  • Smoking
  • Acute Coronary Syndrome

Interventions

BEHAVIORAL

Technique of in-vivo exposure (cigarette) and mental image exposure (craving)

Nicotine replacement

BEHAVIORAL

conventional follow-up

nicotinic substitutes

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • National Cancer Institute, France

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Patrick HENRY, MD,PhD · Assistance Publique - Hôpitaux de Paris

  • Laurent MAGNE · Cabinet MAGNE & GALLY

  • Olivia GALLY · Cabinet MAGNE & GALLY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-10-31
Completion
2010-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00987597 on ClinicalTrials.gov